Phytosterols: From Preclinical Evidence to Potential Clinical Applications
Bahare Salehi, Cristina Quispe, Javad Sharifi‐Rad, Natália Martins, Manisha Nigam, Abhay Prakash Mishra, Д. А. Коновалов, Valeriya Orobinskaya, Ibrahim M. Abu‐Reidah, Wissam Zam, Farukh Sharopov, Tommaso Venneri, Raffaele Capasso, Wirginia Kukuła‐Koch, Anna Wawruszak, Wojciech Koch
Abstract
Phytosterols (PSs) are plant-originated steroids. Over 250 PSs have been isolated, and each plant species contains a characteristic phytosterol composition. A wide number of studies have reported remarkable pharmacological effects of PSs, acting as chemopreventive, anti-inflammatory, antioxidant, antidiabetic, and antiatherosclerotic agents. However, PS bioavailability is a key issue, as it can be influenced by several factors (type, source, processing, preparation, delivery method, food matrix, dose, time of administration into the body, and genetic factors), and the existence of a close relationship between their chemical structures (e.g., saturation degree and side-chain length) and low absorption rates has been stated. In this sense, the present review intends to provide in-depth data on PS therapeutic potential for human health, also emphasizing their preclinical effects and bioavailability-related issues.